X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Unichem Lab with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 UNICHEM LAB   ACTAVIS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
ACTAVIS
Dec-14
UNICHEM LAB/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs38219,418-   
Low Rs23411,844-   
Sales per share (Unadj.) Rs116.33,496.6-  
Earnings per share (Unadj.) Rs-18.9-436.3-  
Cash flow per share (Unadj.) Rs-11.7320.8-  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.60-  
Book value per share (Unadj.) Rs381.07,584.1-  
Shares outstanding (eoy) m70.34265.90-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.64.5 59.3%   
Avg P/E ratio x-16.3-35.8 45.4%  
P/CF ratio (eoy) x-26.248.7 -53.9%  
Price / Book Value ratio x0.82.1 39.2%  
Dividend payout %-26.40-   
Avg Mkt Cap Rs m21,6684,156,317 0.5%   
No. of employees `0002.321.6 10.6%   
Total wages/salary Rs m2,0060-   
Avg. sales/employee Rs Th3,587.843,044.1 8.3%   
Avg. wages/employee Rs Th880.00-   
Avg. net profit/employee Rs Th-583.7-5,371.5 10.9%   
INCOME DATA
Net Sales Rs m8,180929,753 0.9%  
Other income Rs m610-2,320 -26.3%   
Total revenues Rs m8,790927,433 0.9%   
Gross profit Rs m-1,320119,440 -1.1%  
Depreciation Rs m505201,326 0.3%   
Interest Rs m8029,326 0.3%   
Profit before tax Rs m-1,295-113,532 1.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-8,328 0.0%   
Tax Rs m33-5,837 -0.6%   
Profit after tax Rs m-1,331-116,023 1.1%  
Gross profit margin %-16.112.8 -125.6%  
Effective tax rate %-2.65.1 -50.2%   
Net profit margin %-16.3-12.5 130.4%  
BALANCE SHEET DATA
Current assets Rs m23,318489,861 4.8%   
Current liabilities Rs m4,635357,252 1.3%   
Net working cap to sales %228.414.3 1,601.3%  
Current ratio x5.01.4 366.9%  
Inventory Days Days12258 209.9%  
Debtors Days Days12166 183.3%  
Net fixed assets Rs m8,163113,532 7.2%   
Share capital Rs m1410-   
"Free" reserves Rs m26,6600-   
Net worth Rs m26,8012,016,601 1.3%   
Long term debt Rs m31,056,738 0.0%   
Total assets Rs m31,8903,695,765 0.9%  
Interest coverage x-15.2-2.9 528.4%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.30.3 102.0%   
Return on assets %-3.9-2.3 167.2%  
Return on equity %-5.0-5.8 86.3%  
Return on capital %-4.5-3.0 150.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4,3560-   
CASH FLOW
From Operations Rs m-1,123159,657 -0.7%  
From Investments Rs m16,487-382,279 -4.3%  
From Financial Activity Rs m-8,811214,786 -4.1%  
Net Cashflow Rs m6,552-7,837 -83.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.18 Rs / USD

Compare UNICHEM LAB With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare UNICHEM LAB With: STRIDES PHARMA SCIENCE  ABBOTT INDIA  FDC LTD.  NOVARTIS  SUN PHARMA  



Today's Market

Sensex Trades Flat; Realty and Auto Stocks Gain(12:30 pm)

Share markets in India are presently trading on a flat note. Sectoral indices are trading mixed with stocks in the banking sector and energy sector.

Related Views On News

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The 4-Point Plan to Accelerate India to a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Feb 12, 2019

Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Feb 22, 2019 02:25 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS